Found: 9
Select item for more details and to access through your institution.
Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 5, p. 401, doi. 10.1038/nrd3705
- By:
- Publication type:
- Article
Intraperitoneal recombinant interferon-alpha 2b for recurrent malignant ascites due to ovarian cancer.
- Published in:
- 1989
- By:
- Publication type:
- journal article
Breast cancer in men. Clinical features, hormone receptor status, and response to therapy.
- Published in:
- 1987
- By:
- Publication type:
- journal article
The development of denosumab for the treatment of diseases of bone loss and cancer-induced bone destruction.
- Published in:
- Annals of the New York Academy of Sciences, 2012, v. 1263, n. 1, p. 29, doi. 10.1111/j.1749-6632.2012.06674.x
- By:
- Publication type:
- Article
Successful bone marrow transplantation for life threatening xanthogranuloma disseminatum in neurofibromatosis type-1.
- Published in:
- Pediatric Transplantation, 2005, v. 9, n. 4, p. 534, doi. 10.1111/j.1399-3046.2005.00307.x
- By:
- Publication type:
- Article
The value of estrogen and progesterone receptor determinations in advanced breast cancer. Estrogen receptor level but not progesterone receptor level correlates with response to tamoxifen.
- Published in:
- 1991
- By:
- Publication type:
- journal article
Delaying skeletal-related events in a randomized phase 3 study of denosumab versus zoledronic acid in patients with advanced cancer: an analysis of data from patients with solid tumors.
- Published in:
- Supportive Care in Cancer, 2014, v. 22, n. 3, p. 679, doi. 10.1007/s00520-013-2022-1
- By:
- Publication type:
- Article
Pain outcomes in patients with advanced breast cancer and bone metastases.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 4, p. 832, doi. 10.1002/cncr.27789
- By:
- Publication type:
- Article
A single dose of pegfilgrastim compared with daily filgrastim for supporting neutrophil recovery in patients treated for low-to-intermediate risk acute myeloid leukemia: results from a randomized, double-blind, phase 2 trial.
- Published in:
- BMC Cancer, 2008, v. 8, p. 1, doi. 10.1186/1471-2407-8-195
- By:
- Publication type:
- Article